Lung specialist Wolfgang Wodarg has said that there are many risks associated with the vaccine for the H1N1 virus.
He has grave reservations about the firm Novartis who are developing the vaccine and testing it in Germany. The vaccination is injected “with a very hot needle”, Wodarg said.
The nutrient solution for the vaccine consists of cancerous cells from animals and “we do not know if there could be an allergic reaction”.
But more importantly, some people fear that the risk of cancer could be increased by injecting the cells.
The vaccine – as Johannes Löwer, president of the Paul Ehrlich Institute, has pointed out – can also cause worse side effects than the actual swine flu virus.
Wodrag also described people’s fear of the pandemic as an “orchestration”: “It is great business for the pharmaceutical industry,” he told the ‘Neuen Presse’.
Swine flu is not very different from normal flu. “On the contrary if you look at the number of cases it is nothing compared to a normal flu outbreak,” he added.
The chairman of the health committee in the European Council has urged for a careful and calm reaction to the virus.
Up until now, the producers of the vaccine did not know how many orders they would have by the autumn, but the German Government is now a guaranteed customer.
Even the pharmaceutical companies are trying to exploit the fear of the swine flu pandemic.